Controlled dangerous substances; authorizing certain research and clinical trials related to psilocybin and psilocin; requiring registration; providing certain immunities.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2022
Committee Review
Apr 2022
House Passage
Mar 2022
Senate Passage
Governor
Introduced Feb 7, 2022
Last action Apr 14, 2022
Floor votes
How they voted
This bill passed the House by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
20
Key actions
4
Committee
3
Amendments
1
Apr 11, 2022
Upper · Passed
Reported Do Pass, amended by committee substitute Health and Human Services committee; CR filed
upper
Mar 8, 2022
Introduced
First Reading
upper
Mar 8, 2022
Lower · Passed
Engrossed, signed, to Senate
lower
Mar 7, 2022
Committee
Referred for engrossment
lower
Mar 7, 2022
Lower · Passed
Third Reading, Measure passed and Emergency failed: Ayes: 62 Nays: 30; Ayes: 66 Nays: 25
lower
Mar 7, 2022
Introduced
Amended by floor substitute
lower
Feb 16, 2022
Lower · Passed
CR; Do Pass, amended by committee substitute Public Health Committee
lower
Feb 7, 2022
Introduced
First Reading
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 3414
Scope: OK
Hi! I can help you understand HB 3414. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline